Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Versartis, Inc. | 215,755 | reported | 23 Mar 2018 | tx 5+320,100−4,345 |
| Esperion Therapeutics, Inc. | 88,000 | reported | 29 May 2025 | tx 8+227,566 |
| ZEVRA THERAPEUTICS, INC. | 50,000 | reported | 11 Feb 2016 | tx 2+132,035 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 88,000 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 5,150 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 21,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | Esperion Therapeutics, Inc. | 12,376 | 0.00 USD | |
| 28 May 2020 | GRANT_AWARD | Esperion Therapeutics, Inc. | 6,106 | 0.00 USD | |
| 29 May 2019 | GRANT_AWARD | Esperion Therapeutics, Inc. | 9,934 | 0.00 USD | |
| 23 Mar 2018 | SALE | Versartis, Inc. | 4,345 | 1.75 USD | |
| 20 Dec 2017 | GRANT_AWARD | Versartis, Inc. | 93,100 | 0.00 USD | |
| 06 Oct 2017 | GRANT_AWARD | Versartis, Inc. | 82,000 | 0.00 USD | |
| 22 Mar 2017 | GRANT_AWARD | Versartis, Inc. | 45,000 | 0.00 USD | |
| 22 Mar 2017 | GRANT_AWARD | Versartis, Inc. | 100,000 | 0.00 USD | deriv |
| 11 Feb 2016 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 27 May 2015 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 82,035 | 0.00 USD | deriv |